Recorded Chinese product: 复方磺胺嘧啶颗粒复方磺胺嘧啶颗粒
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 药都制药集团股份有限公司Chinese legal name: 药都制药集团股份有限公司
主要成分Active Ingredients
- 甲氧苄啶Jiayang Bianding
- 磺胺脒Huangan Mi
药物知识说明
甲氧苄啶是一种在国家药监局注册认定的药品。该药品含有甲氧苄啶、磺胺脒-fa347d92等成分。
该药品关联的活性成分包括:甲氧苄啶Jiayang Bianding、磺胺脒Huangan Mi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:药都制药集团股份有限公司Chinese legal name: 药都制药集团股份有限公司。
您可以探索含有相同成分的其他药品:甲氧苄啶-7f323670成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 复方磺胺嘧啶颗粒) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 甲氧苄啶Jiayang Bianding, 磺胺脒Huangan Mi.
Manufacturers recorded for this product: 药都制药集团股份有限公司Chinese legal name: 药都制药集团股份有限公司.
Explore other medicines containing the same ingredient: 甲氧苄啶 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方磺胺嘧啶颗粒Recorded Chinese product: 复方磺胺嘧啶颗粒
- 剂型Dosage form: 颗粒剂Granules
- 规格Specification: 磺胺嘧啶0.4g,甲氧苄啶50mgRecorded Chinese specification: 磺胺嘧啶0.4g,甲氧苄啶50mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 药都制药集团股份有限公司Chinese legal name: 药都制药集团股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H13023621
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H13023621
Manufacturer
Chinese legal name: 药都制药集团股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H13023621
生产企业
药都制药集团股份有限公司(国产)
适应症
用于上呼吸道感染、肠炎、中耳炎、结膜炎、疮疖、脓肿。
用法用量
口服。未满1岁半包;1~2岁1包;3~5岁1包半;6~8岁2包;9~12岁2包半,一日4次,首次加倍服用。
不良反应
尚不明确。
禁忌
1.对磺胺类药物和甲氧苄啶过敏者禁用;|2.孕妇、哺乳期妇女禁用;|3.2个月以下婴儿、早产儿禁用;|4.肝肾功能不良者、血液病患者(如白细胞减少、血小板减少、紫癜症等)禁用。
贮藏
密封,置阴凉处。
规格
磺胺嘧啶0.4g,甲氧苄啶50mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.